Physician profile
Justin D Johnson
NPI 1013179001
$7,044.38
in general payments reported to CMS, 2019-2025
36 companies · $1,347 in 2025
The $1,347 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $311 · 2021: $181 · 2022: $1,884 · 2023: $1,869 · 2024: $465 · 2025: $1,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,021 · Travel and Lodging: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,021.06 |
| Travel and Lodging | $660.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,703.67 | 2020-2025 | Ams 700, General - Kidney Stone Disease, Axonics |
| Teleflex LLC | $1,390.94 | 2023-2025 | Urolift |
| Astellas Pharma US INC | $570.09 | 2019-2025 | Xtandi |
| Axonics, INC. | $569.60 | 2022-2024 | Axonics |
| Procept Biorobotics Corporation | $287.23 | 2024-2025 | Aquabeam System |
| Neotract INC. | $274.44 | 2019 | |
| Mallinckrodt Enterprises LLC | $244.86 | 2019 | |
| Medtronic USA, INC. | $190.50 | 2020 | |
| Sumitomo Pharma America, INC. | $181.97 | 2023-2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $146.77 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $121.46 | 2019-2025 | |
| Antares Pharma, INC. | $119.76 | 2019-2025 | Xyosted |
| Healthtronics Stone Solutions, LLC | $116.88 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Angiodynamics, INC. | $106.55 | 2022 | |
| Blue Earth Diagnostics | $104.96 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $88.27 | 2019-2022 | |
| Abbvie INC. | $85.78 | 2023-2025 | |
| Urogen Pharma, INC. | $81.20 | 2025 | |
| Janssen Biotech, INC. | $78.15 | 2019-2024 | Erleada |
| Myovant Sciences INC. | $72.95 | 2022 | |
| Rochester Medical Corporation | $64.07 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $63.38 | 2019-2024 | Bard Urinary Drainage Bag |
| Medtronic, INC. | $58.66 | 2024-2025 | Interstim |
| Aytu Biopharma, INC. | $50.46 | 2019 | |
| Olympus America INC. | $40.94 | 2025 | Itind System |
| Zyla Life Sciences, INC. | $29.24 | 2019 | |
| Innovation Technologies INC | $28.78 | 2024 | Irrisept |
| Endo USA, INC. | $28.15 | 2025 | Xiaflex |
| Agiliti Surgical, INC. | $27.11 | 2025 | Boston Scientific Lumenis Pulse Holmium Laser (30h, 50h, 100), Boston Scientific Lumenis Versapulse Powersuite Lasers, Lumenis Novus Spectra Ktp Laser |
| Halozyme INC | $22.37 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $21.80 | 2019 | |
| Sandoz INC. | $17.95 | 2025 | Jubbonti, Wyost |
| Immunitybio, INC. | $14.48 | 2024 | |
| Endo Pharmaceuticals INC. | $14.29 | 2023 | Xiaflex |
| Ethicon US, LLC | $13.73 | 2024 | Echelon Endopath |
| Merck Sharp & Dohme LLC | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.